An Amgen executive refutes accusations that the company published misleading results of its mid-90s clinical trial testing an anemia drug.
The Scientist
Most Recent
The regulatory agency will allow early-stage breast cancer patients to try experimental drugs previously reserved for those with advanced disease.
Whether working for a pharmaceutical giant or a biotech start-up with a unique vision, researchers who responded to this year’s Best Places to Work in Industry survey are translating society’s most pressing scientific needs into a new generation of d
Gene therapies typically involve the introduction of genetic material into target cells to replace or supplement an existing, usually dysfunctional, gene. Techniques for delivering the corrective payload vary widely. Many gene therapies utilize modif
EDITOR'S CHOICE IN MICROBIOLOGY The paper S. Alsford et al., “High-throughput decoding of antitrypanosomal drug efficacy and resistance,” Nature, 482:232-36, 2012. The finding Trypanosoma brucei, the single-cell protozoan that causes the tropical
Much has changed in the 10 years since our first survey of industry researchers. Large companies are now looking to small, nimble ones for services as well as innovation.
As biologic drug patents begin to expire, generic versions will hit the market—but how will they be regulated?
New research suggests that controlling cytoskeletal dynamics in sperm accessory cells may help regulate male fertility.
The FDA approves drugs faster and earlier than regulatory agencies in other countries.
The US Food and Drug Administration has relaxed some of the rules governing how companies must test the sterility of materials used to make biologic drugs.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
